COGNEX CORP
For the period ended Apr 5, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Apr 5, 2026 · Filed May 7, 2026
CGNX$50.34+5.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Shareholders’ Equity
(In thousands of dollars, except per share amounts)
| Common Stock · AdditionalPaid-in Capital · Retained Earnings · AccumulatedOtherComprehensiveLoss · TotalShareholders’Equity | ||||||
|---|---|---|---|---|---|---|
| Shares · Par Value | ||||||
| Balance as of December 31, 2025 | 166,997 | $334 | $1,138,708 | $406,355 | $(53,496) | $1,491,901 |
| Net issuance of common stock under stock plans | 1,905 | 4 | 44,286 | — | — | 44,290 |
| Repurchase of common stock | (2,375) | (5) | — | (98,990) | — | (98,995) |
| Excise tax on repurchase of common stock | — | — | — | (430) | — | (430) |
| Stock-based compensation expense | — | — | 11,933 | — | — | 11,933 |
| Payment of dividends ($0.085 per common share) | — | — | — | (14,196) | — | (14,196) |
| Net income | — | — | — | 51,704 | — | 51,704 |
| Net unrealized gain (loss) on available-for-sale investments, net of tax of $(726) | — | — | — | — | (2,227) | (2,227) |
| Reclassification of net realized (gain) loss on the sale of available-for-sale investments | — | — | — | — | (28) | (28) |
| Foreign currency translation adjustment | — | — | — | — | (4,983) | (4,983) |
| Balance as of April 5, 2026 (unaudited) | 166,527 | $333 | $1,194,927 | $344,443 | $(60,734) | $1,478,969 |
| Common Stock · AdditionalPaid-in Capital · Retained Earnings · AccumulatedOtherComprehensiveLoss · TotalShareholders’Equity | ||||||
|---|---|---|---|---|---|---|
| Shares · Par Value | ||||||
| Balance as of December 31, 2024 | 170,434 | $341 | $1,090,638 | $499,303 | $(72,777) | $1,517,505 |
| Net issuance of common stock under stock plans | 478 | 1 | (2,588) | — | — | (2,587) |
| Repurchase of common stock | (3,047) | (6) | — | (103,407) | — | (103,413) |
| Stock-based compensation expense | — | — | 9,939 | — | — | 9,939 |
| Payment of dividends ($0.080 per common share) | — | — | — | (13,550) | — | (13,550) |
| Net income | — | — | — | 23,603 | — | 23,603 |
| Net unrealized gain (loss) on available-for-sale investments, net of tax of $875 | — | — | — | — | 2,711 | 2,711 |
| Reclassification of net realized (gain) loss on the sale of available-for-sale investments | — | — | — | — | (27) | (27) |
| Foreign currency translation adjustment | — | — | — | — | 11,447 | 11,447 |
| Balance as of March 30, 2025 (unaudited) | 167,865 | $336 | $1,097,989 | $405,949 | $(58,646) | $1,445,628 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.